Synthetic molecular probes, chemosensors, and nanosensors used in combination with
innovative assay protocols hold great potential for the development of robust, low-cost, and …

Detailed metabolic profiling in large-scale epidemiologic studies has uncovered novel
biomarkers for cardiometabolic diseases and clarified the molecular associations of …

Metabolomic studies of body fluids show that immune‐mediated inflammatory diseases such
as rheumatoid arthritis (RA) are associated with metabolic disruption. This is likely to reflect …

Psoriasis is a common inflammatory skin disease involving interactions between
keratinocytes and immune cells that significantly affects the quality of life. It is characterized …

Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn's disease and
ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise …

Rheumatoid arthritis (RA) is an autoimmune disease accompanied by metabolic alterations.
The metabolic profiles of patients with RA can be determined using targeted and non …

Escherichia coli ordinarily resides in the lower gastrointestinal tract in humans, but some
strains, known as Uropathogenic E. coli (UPEC), are also adapted to the relatively harsh …

Inflammatory bowel disease (IBD) is a chronic, complex relapsing disorder characterised by
immune dysregulation, gut microbiota alteration, and disturbed intestinal permeability. The …

Autoimmune diseases (ADs) are rapidly increasing worldwide and accumulating data
support a key role of disrupted metabolism in ADs. This study aimed to identify an improved …

Introduction Psoriatic arthritis (PsA) is a chronic inflammatory disease that frequently
develops in patients with psoriasis (PsO) but can also occur spontaneously. As a result, PsA …